Livzon Pharmaceutical Group ( (HK:1513) ) just unveiled an update.
Livzon Pharmaceutical Group Inc. has announced changes in its accounting policies in line with the latest requirements from the Ministry of Finance. These changes, effective from January 2024, involve the classification of liabilities and disclosure of supplier financing arrangements, impacting how the company reports its financial obligations and liquidity risks. These adjustments are expected to enhance transparency and compliance with updated accounting standards, potentially affecting stakeholders’ understanding of the company’s financial health.
More about Livzon Pharmaceutical Group
Livzon Pharmaceutical Group Inc. is a company operating in the pharmaceutical industry, focusing on the development, production, and distribution of pharmaceutical products and services. The company is part of a larger group that includes various subsidiaries, which collectively aim to address healthcare needs through innovative solutions.
YTD Price Performance: -1.45%
Technical Sentiment Signal: Strong Sell
Current Market Cap: $3.99B
Learn more about 1513 stock on TipRanks’ Stock Analysis page.